Is BLT next? Novartis to pay $8.7B for AxeXis which is developing an orphan drug. https://globenewswire.com/news-rele...s-a-gene-therapy-and-Neuroscience-leader.html
AUQ Alara Resources (ASX:AUQ) is driving Oman into a renewable renaissance with accelerating copper production